Embleema provides an end-to-end data platform that integrates clinical, real-world, and molecular data to generate regulatory-grade evidence for personalized medicine. This technology accelerates participant recruitment and data collection, enabling faster FDA approvals and reducing costs for rare disease research.
Funding
$3.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
PFounders
Product
Problem
Drug development for rare diseases is hindered by challenges in patient recruitment, data collection, and the integration of diverse data types (clinical, real-world, and molecular). Traditional methods are often slow, costly, and lack the standardization required for regulatory submissions.
Solution
Embleema offers a data platform designed to streamline personalized medicine research and development. The platform integrates clinical, real-world, and molecular data, providing a unified environment for generating regulatory-grade evidence. It facilitates faster participant recruitment through online and in-clinic channels and enables secure data collection and sharing. The platform's blockchain component enforces patient consents and provides a full audit trail. Evidence generation occurs within the HIVE platform, with a pathway for direct FDA review, aiming to accelerate regulatory approvals and reduce costs.
Target Audience
The primary audience includes researchers, pharmaceutical sponsors, and biotech companies focused on rare diseases and personalized medicine, as well as patients participating in clinical trials.
Features
- Study Designer: Configures studies within the platform.
- Participant Recruitment: Online and in-investigation center recruitment capabilities.
- Secure Data Sharing: Enables participants and investigators to securely share data.
- Blockchain Integration: Enforces patient consents and provides an audit trail.
- HIVE Platform: Generates evidence for regulatory submissions.
- Standardized Data: Provides standardized and de-identified data at the patient level.
- Patient App: User-friendly app for patient involvement and data collection.